NVO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Novo Nordisk A/S's other long-term assets for the quarter that ended in Sep. 2016 was $405 Mil.
Novo Nordisk A/S's quarterly other long-term assets declined from Mar. 2016 ($897 Mil) to Jun. 2016 ($674 Mil) and declined from Jun. 2016 ($674 Mil) to Sep. 2016 ($405 Mil).
Novo Nordisk A/S's annual other long-term assets increased from Dec. 2013 ($777 Mil) to Dec. 2014 ($895 Mil) and increased from Dec. 2014 ($895 Mil) to Dec. 2015 ($993 Mil).
Novo Nordisk A/S Annual Data
|Other Long-Term Assets||508||617||383||321||373||475||395||777||895||993|
Novo Nordisk A/S Quarterly Data
|Other Long-Term Assets||878||914||895||1,061||1,002||931||993||897||674||405|